May 9, 2022 - Page 2 Of 7 - Medical Device News Magazine

Florida / New York

Medical Device News Magazine

A Publication for the Practicing Medical Specialist, Industry Executive & Investor

Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain

Cybin and Kernel Announce Results from Kernel Flow® Piloting of Feasibility Study Measuring Ketamine’s Effects on the Brain

Medical Device News MagazineMay 9, 2022May 10, 20220

Preliminary data confirm Flow’s ability to successfully measure neuro-effect of ketamine over 10 days reports Kernel.

Request Information

Copyright © 2025 Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc. All Rights Reserved

Hours:

M – F 8 am – 5 pm

Florida / New York

Phone: 561.316.3330